S
Sanjay Kaul
Researcher at Cedars-Sinai Medical Center
Publications - 222
Citations - 25862
Sanjay Kaul is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Randomized controlled trial & Myocardial infarction. The author has an hindex of 67, co-authored 215 publications receiving 22556 citations. Previous affiliations of Sanjay Kaul include University of California, Los Angeles & Baylor University Medical Center.
Papers
More filters
Journal ArticleDOI
The disconnect between practice guidelines and clinical practice--stressed out.
George A. Diamond,Sanjay Kaul +1 more
TL;DR: Clinical practice guidelines currently recommend revascularization when stress testing reveals demonstrable myocardial ischemia despite optimal medical management, but the guidelines are not as clear as they might be on this matter.
Journal ArticleDOI
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Javed Butler,Milton Packer,Stephen J. Greene,Stephen J. Greene,Mona Fiuzat,Stefan D. Anker,Kevin J. Anstrom,Peter E. Carson,Lauren B. Cooper,Gregg C. Fonarow,Adrian F. Hernandez,Adrian F. Hernandez,James L. Januzzi,Mariell Jessup,Rita R. Kalyani,Sanjay Kaul,Mikhail Kosiborod,Mikhail Kosiborod,JoAnn Lindenfeld,Darren K. McGuire,Marc S. Sabatine,Scott D. Solomon,John R. Teerlink,John R. Teerlink,Muthiah Vaduganathan,Clyde W. Yancy,Norman Stockbridge,Christopher M. O'Connor +27 more
TL;DR: This topic was discussed by researchers, clinicians, industry sponsors, regulators, and representatives from professional societies, who convened on the US Food and Drug Administration campus on March 6, 2019, and this report summarizes these discussions and the key takeaway messages from this meeting.
Journal ArticleDOI
A Prospective, Nonrandomized, Open-Labeled Pilot Study Investigating the Use of Magnesium in Patients Undergoing Nonacute Percutaneous Coronary Intervention with Stent Implantation:
Vladimir Rukshin,Raul D. Santos,Mitch Gheorghiu,Prediman K. Shah,Saibal Kar,Sriram Padmanabhan,Babak Azarbal,Vivian Tsang,Raj Makkar,Bruce Samuels,Norman E. Lepor,Ivor Geft,Steve Tabak,Mehran Khorsandhi,Neil A. Buchbinder,Neil Eigler,Bojan Cercek,Keta Hodgson,Sanjay Kaul +18 more
TL;DR: Intravenous magnesium sulfate has been demonstrated as a feasible and safe agent in patients undergoing nonacute percutaneous coronary intervention with stent implantation and a randomized clinical trial comparing magnesium with glycoprotein inhibitors during percutaneously coronary intervention is warranted.
Journal ArticleDOI
Prevention and treatment: a tale of two strategies.
George A. Diamond,Sanjay Kaul +1 more
TL;DR: It was the best of times, the worst of times , it was the age of wisdom, it wasThe age of foolishness, the epoch of belief, the period of belief and incredulity, the season of Light and the era of Darkness.
Journal ArticleDOI
Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease
TL;DR: Findings suggest that the positive relationship of elevated apolipoprotein B to CAD may be, in part, related to its prothrombotic effects.